Novo Nordisk CEO Lars Fruergaard Jorgensen discusses earnings as well as the competitive landscape in the pharmaceutical sector. He speaks with Bloomberg's Katie Greifeld and Alix Steel.

Alex Rodriguez Talks MLB's Collective Bargaining Deal & Sports Investing
07:34

Brookfield Asset Management CEO Connor Teskey Talks Private Credit
08:46

Ariel Investments Founder John Rogers Talks US Economy
13:04